Company intelligence / Profile preview

Make Cheese

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Make Cheese is a biotechnology company specializing in precision fermentation to produce animal-free dairy proteins. By leveraging synthetic biology and engineered microbial hosts, the company creates bio-identical casein and whey proteins that replicate the functional properties of traditional dairy without the need for animal farming. Their technology aims to provide sustainable, lactose-free, and cholesterol-free alternatives for the global food and healthcare industries. The company is currently focused on optimizing its fermentation yields and scaling production for commercial partnerships.

Therapeutic areas: GastroenterologyMetabolic Disorders
Modalities: Microbial therapyRecombinant proteinCell therapy
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Make Cheese.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Make Cheese.

Explore the full profile